Actionable news
0
All posts from Actionable news
Actionable news in IMMU: Immunomedics, Inc.,

Immunomedics, Inc.

ETFs with exposure to Immunomedics, Inc.Here are 5 ETFs with the largest exposure to IMMU-US. Comparing the performance and risk of Immunomedics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility.

TickerFund NameIMMU-US Exposure (%)1 Year Price Performance (%)1 Year Volatility (%)Net Expense Ratio (%)Number of Holdings
PTH-USPowerShares DWA Healthcare Momentum Portfolio2.553.519.80.653
DWAS-USPowerShares DWA SmallCap Momentum Portfolio0.84336.315.40.6200
XBI-USSPDR S&P Biotech ETF0.80446.726.70.35103
BTEC-USPrincipal Healthcare Innovators Index ETF0.492625.20.42142
FYC-USFirst Trust Small Cap Growth AlphaDEX Fund0.4234.714.80.7262
IMMU-USImmunomedics, Inc.1004002.501

Use our ETF screener to find ETFs that hold IMMU-US along with other stocks

Click here to view

ETFs with exposure to stocks in the same focus area as Immunomedics, Inc..Here are 5 ETFs with the largest exposure to stocks in the same focus area and region as IMMU-US. These ETFs may not have the highest percentage of Immunomedics, Inc., but offer a broader sector/region exposure further minimizing single stock risk. Comparing the performance and risk of Immunomedics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility.

TickerFund NameIMMU-US Exposure (%)Sector Exposure (%)1 Year Price Performance (%)1 Year Volatility (%)Net Expense Ratio (%)Number of Holdings
IBB-USiShares Nasdaq Biotechnology ETF0.2639.119.1200.47160
PBE-USPowershares Dynamic Biotechnology & Genome Portfoliominuscule37.323.222.70.5931
BBH-USVanEck Vectors Biotech ETFminuscule3619.418.20.3526
XBI-USSPDR S&P Biotech ETF0.8043246.726.70.35103
CNCR-USLoncar Cancer Immunotherapy ETFminuscule30.11928.80.7930
IMMU-USImmunomedics, Inc.1001004002.501

Use our natural language search to find ETFs in any focus area

Click here to view

The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party's use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any of our reports, you're agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website www.analytixinsight.com.


More